Cargando…

Angiogenesis inhibitors for the treatment of small cell lung cancer (SCLC): A meta-analysis of 7 randomized controlled trials

BACKGROUND: This study aimed to assess the effectiveness and safety of angiogenesis inhibitors for the treatment of patients with small cell lung cancer (SCLC) via meta-analysis. METHODS: Electronic databases including PubMed, Embase, and Cochrane Library were searched to look for eligible studies t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qing, Wu, Tao, Jing, Li, Li, Miao-Jing, Tian, Tao, Ruan, Zhi-Ping, Liang, Xuan, Nan, Ke-Jun, Liu, Zhi-Yan, Yao, Yu, Guo, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380252/ https://www.ncbi.nlm.nih.gov/pubmed/28353568 http://dx.doi.org/10.1097/MD.0000000000006412

Ejemplares similares

Notch Signaling Components: Diverging Prognostic Indicators in Lung Adenocarcinoma
por: Liu, Zhi-Yan, et al.
Publicado: (2016)

D-D and PLR, NLR combined forecasting first-line treatment: The short-term curative effect and prognosis of patients with SCLC
por: Hu, Hui, et al.
Publicado: (2023)

Better survival and prognosis in SCLC survivors after combined second primary malignancies: A SEER database-based study
por: Wang, Silin, et al.
Publicado: (2023)

The efficacy and safety of PD-1/PD-L1 inhibitors versus chemotherapy in patients with previously treated advanced non-small-cell lung cancer: A meta-analysis
por: Wu, Lin-guang-jin, et al.
Publicado: (2021)

Primary acinic cell carcinoma of the trachea: A case report and literature review
por: Yang, Mai-Qing, et al.
Publicado: (2023)

Potential roles of tumor microenvironment in gefitinib-resistant non-small cell lung cancer: A narrative review
por: Chen, Mu-Tong, et al.
Publicado: (2023)

Adverse cardiac events in the treatment of non-small cell lung cancer with programmed death-1and programmed death-ligand 1 inhibitors: A protocol for systematic review and meta-analysis
por: Li, Honglin, et al.
Publicado: (2020)

Small cell lung cancer transformation after EGFR-TKIs treatment in lung adenocarcinoma: A case report and literatures review
por: Chen, Xiaoli, et al.
Publicado: (2023)

Transformation of NSCLC to SCLC after 1st- and 3rd-generation EGFR-TKI resistance and response to EP regimen and erlotinib: 2 CARE-compliant case reports
por: Lai, Lin, et al.
Publicado: (2021)

Tracheoesophageal fistula associated with bevacizumab after thoracic radiotherapy in non-small cell lung cancer: A case report
por: Zhang, Tao, et al.
Publicado: (2020)

Real-world treatment efficacy of anti-programmed death-1 combined with anti-angiogenesis therapy in non-small cell lung cancer patients
por: Qiu, Lupeng, et al.
Publicado: (2020)

A case report of immune checkpoint inhibitor nivolumab combined with anti-angiogenesis agent anlotinib for advanced esophageal squamous cell carcinoma
por: Tang, Yong, et al.
Publicado: (2019)

Identification and verification of an exosome-related gene risk model to predict prognosis and evaluate immune infiltration for colorectal cancer
por: Shao, Huan, et al.
Publicado: (2023)

Mutation differences in circulating tumor DNAs from non-small cell lung cancer patients between Uygur and Han populations
por: Wang, Yuli, et al.
Publicado: (2021)

Efficacy of immune checkpoint inhibitors in the treatment of non-small cell lung cancer patients with different genes mutation: A meta-analysis
por: Zhang, Rui, et al.
Publicado: (2021)

Expression of estrogen receptor beta and overall survival in non-small cell lung cancer patients: Protocol for a systematic review and meta-analysis of cohort studies
por: Chen, Haisheng, et al.
Publicado: (2019)

Comparative effectiveness of tamoxifen, toremifene, letrozole, anastrozole, and exemestane on lipid profiles in breast cancer patients: A network meta-analysis
por: He, Tao, et al.
Publicado: (2020)

Prognostic value of ATPase family, AAA+ domain containing 2 expression in human cancers: A systematic review and meta-analysis
por: Han, Hua-Jing, et al.
Publicado: (2019)

Small-arc volumetric-modulated arc therapy: A new approach that is superior to fixed-field IMRT in optimizing dosimetric and treatment-relevant parameters for patients undergoing whole-breast irradiation following breast-conserving surgery
por: Yu, Jing, et al.
Publicado: (2016)

Do renin–angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: Evidence from a meta-analysis including 55 studies
por: Sun, Hong, et al.
Publicado: (2017)

High VEGFR1/2 expression levels are predictors of poor survival in patients with cervical cancer
por: Dang, Yun-Zhi, et al.
Publicado: (2017)

The prognostic value of B7-H4 in pancreatic cancer: Systematic review and meta-analysis
por: Chen, Xin, et al.
Publicado: (2018)

Long non-coding RNA small nucleolar RNA host gene 7 expression level in prostate cancer tissues predicts the prognosis of patients with prostate cancer
por: Xia, Qier, et al.
Publicado: (2020)

EGFR mutation testing in blood for guiding EGFR tyrosine kinase inhibitor treatment in patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis
por: Yuan, Jin-Qiu, et al.
Publicado: (2017)

Prevalence and correlation of anxiety and depression on the prognosis of postoperative non-small-cell lung cancer patients in North China
por: Huang, Xuan, et al.
Publicado: (2020)

Plasma angiopoietin-2 is persistently elevated after non-small cell lung cancer surgery and stimulates angiogenesis in vitro
por: Zhou, Leng, et al.
Publicado: (2016)

Relationship between quantitative contrast-enhanced ultrasonography parameters and angiogenesis in primary small hepatocellular carcinoma: A retrospective study
por: Deng, Shuhao, et al.
Publicado: (2021)

The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors
por: Liu, Na, et al.
Publicado: (2022)

Nivolumab plus regorafenib in patients with small bowel adenocarcinoma: A case report
por: Zhang, Gairong, et al.
Publicado: (2021)

A nationwide analysis of desmoplastic small round cell tumor
por: Xiang, Tao, et al.
Publicado: (2020)

The association between statin use and prognosis in esophageal cancer patients: A meta-analysis
por: Lv, Jing, et al.
Publicado: (2023)

Real-world treatment patterns and survival for locally advanced esophageal squamous cell carcinoma
por: Luo, Hua-Chun, et al.
Publicado: (2023)

MMP7 as a potential biomarker of colon cancer and its prognostic value by bioinformatics analysis
por: Chen, Li, et al.
Publicado: (2021)

The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature
por: Ding, Lin, et al.
Publicado: (2016)

Intelectin-1 is a novel prognostic biomarker for hepatocellular carcinoma
por: Li, Jiang, et al.
Publicado: (2023)

Single-cell transcriptional profiling reveals the heterogeneity in embryonal rhabdomyosarcoma
por: Hong, Bo, et al.
Publicado: (2021)

Simultaneous development of pneumonitis and autoimmune diabetes secondary to immune checkpoint inhibitor treatment with durvalumab in an advanced small cell lung cancer patient: A case report
por: Wen, Yan-Ping, et al.
Publicado: (2022)

Efficacy and safety of bevacizumab-based maintenance therapy in metastatic colorectal cancer: A meta-analysis
por: Ma, Hongbo, et al.
Publicado: (2019)

Prognostic significance of PTOV1 expression in cancers: A protocol for systematic review and meta-analysis
por: Yang, Yue, et al.
Publicado: (2021)

Trefoil Factor 3 as a Novel Biomarker to Distinguish Between Adenocarcinoma and Squamous Cell Carcinoma
por: Wang, Xiao-Nan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5rohg7sj3n224b1n3495sq3h5k